DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

Geron Corp (NASDAQ: GERN)

2.25 -0.06 (-2.60%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GERN $2.25 -2.60%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.31
Previous Close $2.31
Daily Range $2.19 - $2.34
52-Week Range $1.39 - $7.79
Market Cap $353.0M
P/E Ratio -9.24
Dividend (Yield) $0.00 (0.0%)
Volume 4,186,723
Average Daily Volume 1,915,957
Current FY EPS -$0.23

Sector

Healthcare

Industry

Drugs

Geron Corp (GERN) Description

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. Website: http://www.geron.com/

News & Commentary Rss Feed

3 Longtime Losers About to See Green?

These 3 biotechs have lost tons of money every year so far in the 21st century. But could profits be on the horizon?

Living Longer And Making Money: Life Extending Businesses

Why You Shouldn't Bet Against Geron Corporation (GERN) Stock - Tale of the Tape

Geron: Best Buy In The Market

Geron's (GERN) CEO John Scarlett on Q2 2014 Results - Earnings Call Transcript

Geron's (GERN) CEO John Scarlet on Q2 2014 Results - Earnings Call Transcript

Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market

Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation

Better Buy: Dynavax Technologies Corp. vs. Geron Corp.

Dynavax Technologies Corp. and Geron Corp. have pending catalysts that could cause their shares to double from current levels. Here's a Foolish look at which company offers the better risk-to-reward profile.

Geron Corp. (GERN) Jumps: Stock Moves 8.1% Higher - Tale of the Tape

See More GERN News...

GERN's Top Competitors

GERN $2.25 (-2.60%)
Current stock: GERN
AMGN $144.01 (1.40%)
Current stock: AMGN
GILD $105.96 (0.03%)
Current stock: GILD
CELG $93.85 (0.62%)
Current stock: CELG